| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H10N4OS |
| Molecular Weight | 234.278 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(=O)\C(=N\NC(N)=S)C2=C1C=CC=C2
InChI
InChIKey=DLGSOJOOYHWROO-XYOKQWHBSA-N
InChI=1S/C10H10N4OS/c1-14-7-5-3-2-4-6(7)8(9(14)15)12-13-10(11)16/h2-5H,1H3,(H3,11,13,16)/b12-8+
| Molecular Formula | C10H10N4OS |
| Molecular Weight | 234.278 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
Patents
Sample Use Guides
The present recommendations are that adults should receive 6 g. methisazone (four capsules of Marboran) a day, taken 3 g. in the morning and 3 g. in the evening. Dosage is halved for children between 3 and 10 and proportionately reduced still
further for infants.
Route of Administration:
Oral
